• $18.1M
    Market Cap
  • 26.01%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 55
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.09
$0.12
$0.09
1-Year Range
$0.04
$0.15
$0.09
Latest Close$0.09
Change
-$0.02 (-22.09%)
Volume13,633
Market Cap$18.1M
Shares Outstanding90.5M
P/E (TTM)-2.75
Diluted EPS (TTM)-$0.07
Enterprise Value$16.7M

Information as of 06/23/2026

Company Profile

NYMOX PHARM CORP
$18.1M
Market Cap
-$6.6M
Net Income
Sector: Healthcare
Industry: Biotechnology

NYMOX PHARM CORP

Key Executives

  • Patrick Doody
  • Lin Dodd
  • Paul Averback DABP

Current Ownership Distribution

  • Other94.5M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Insiders0 (0.00%)